JP Morgan Chase
EW icon

JP Morgan Chase’s Edwards Lifesciences EW Stock Holding History

JP Morgan Chase’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12M Buy
100,000
+25,000
+33% +$2.09M ﹤0.01% 2883
2026
Q1 		$5.96M Sell
75,000
-179,500
-71% -$14.8M ﹤0.01% 3152
2025
Q4 		$21.7M Buy
254,500
+138,300
+119% +$11.3M ﹤0.01% 1999
2025
Q3 		$9.04M Buy
116,200
+43,900
+61% +$3.43M ﹤0.01% 2809
2025
Q2 		$5.65M Sell
72,300
-23,800
-25% -$1.77M ﹤0.01% 3032
2025
Q1 		$6.97M Buy
96,100
+14,700
+18% +$1.05M ﹤0.01% 2874
2024
Q4 		$6.03M Buy
81,400
+79,600
+4,422% +$5.57M ﹤0.01% 3190
2024
Q3 		$119K Sell
1,800
-31,400
-95% -$2.28M ﹤0.01% 5627
2024
Q2 		$3.07M Sell
33,200
-66,800
-67% -$5.92M ﹤0.01% 3422
2024
Q1 		$9.56M Hold
100,000
– – ﹤0.01% 2533
2023
Q4 		$7.63M Buy
+100,000
New +$6.96M ﹤0.01% 2724
2022
Q2 		– Sell
-60,000
Closed -$7.06M – 6569
2022
Q1 		$7.06M Buy
+60,000
New +$6.73M ﹤0.01% 2703
2020
Q4 		– Sell
-35,000
Closed -$2.74M – 5708
2020
Q3 		$2.74M Buy
+35,000
New +$2.73M ﹤0.01% 3016
2020
Q1 		– Sell
-99,000
Closed -$7.7M – 5401
2019
Q4 		$7.7M Hold
99,000
– – ﹤0.01% 2344
2019
Q3 		$7.26M Hold
99,000
– – ﹤0.01% 2383
2019
Q2 		$6.12M Sell
99,000
-343,200
-78% -$20.8M ﹤0.01% 2480
2019
Q1 		$28.2M Buy
442,200
+380,400
+616% +$21.7M 0.01% 1303
2018
Q4 		$3.15M Buy
+61,800
New +$3.13M ﹤0.01% 2931
2017
Q1 		– Sell
-15,000
Closed -$469K – 5096
2016
Q4 		$469K Sell
15,000
-135,000
-90% -$4.37M ﹤0.01% 3805
2016
Q3 		$6.03M Sell
150,000
-67,500
-31% -$2.54M ﹤0.01% 2120
2016
Q2 		$7.23M Buy
217,500
+7,500
+4% +$257K ﹤0.01% 2053
2016
Q1 		$6.17M Buy
210,000
+188,949
+898% +$5.21M ﹤0.01% 2083
2015
Q4 		$554K Buy
+21,051
New +$547K ﹤0.01% 3347
2015
Q1 		– Sell
-159,600
Closed -$3.39M – 4112
2014
Q4 		$3.39M Buy
+159,600
New +$3.21M ﹤0.01% 2653

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

JP Morgan Chase's EW Position: Q2 2026 in Review

JP Morgan Chase increased its Edwards Lifesciences (EW) stake by 4.8% in Q2 2026, buying an estimated $87M and bringing the position to 22,783,175 shares worth $2.08B. The position accounts for 0.12% of the portfolio, ranked #169.

JP Morgan Chase first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.22B in Q4 2025. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • JP Morgan Chase held 22,783,175 shares of Edwards Lifesciences worth $2.08B as of Q2 2026.
  • JP Morgan Chase bought 1,038,463 Edwards Lifesciences shares in Q2 2026, an estimated $87M.
  • Edwards Lifesciences made up 0.12% of JP Morgan Chase's portfolio in Q2 2026, its #169 holding.
  • JP Morgan Chase first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Edwards Lifesciences position peaked at $2.22B in Q4 2025.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.